Extended interval dosing strategies in multiple sclerosis : insights from natalizumab and ocrelizumab trials
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:271 |
|---|---|
| Enthalten in: |
Journal of neurology - 271(2024), 4 vom: 01. März, Seite 2141-2143 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zid, Yasmin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
A10SJL62JY |
|---|
| Anmerkungen: |
Date Completed 28.03.2024 Date Revised 30.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00415-024-12273-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369265408 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369265408 | ||
| 003 | DE-627 | ||
| 005 | 20240331001048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240304s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00415-024-12273-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1357.xml |
| 035 | |a (DE-627)NLM369265408 | ||
| 035 | |a (NLM)38436677 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zid, Yasmin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extended interval dosing strategies in multiple sclerosis |b insights from natalizumab and ocrelizumab trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.03.2024 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Natalizumab |2 NLM | |
| 650 | 7 | |a ocrelizumab |2 NLM | |
| 650 | 7 | |a A10SJL62JY |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 700 | 1 | |a Robertson, Neil P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neurology |d 1974 |g 271(2024), 4 vom: 01. März, Seite 2141-2143 |w (DE-627)NLM000508543 |x 1432-1459 |7 nnns |
| 773 | 1 | 8 | |g volume:271 |g year:2024 |g number:4 |g day:01 |g month:03 |g pages:2141-2143 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00415-024-12273-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 271 |j 2024 |e 4 |b 01 |c 03 |h 2141-2143 | ||